Wendell Amy McBride

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
8 38% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 122%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Wendell Amy McBride's trades of AxoGen, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
420.30
Quantity 13,510 +2.9%
Value US$1,158,448
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
151.26
Quantity 80,916
Value US$2,212,561
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
220.81
Quantity 1,290 -6.1%
Value US$3,283,688
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
42.60
Quantity 1,647
Value US$70,163
Transaction date
Purchase
Price
68.03
Quantity 1,475 +41.4%
Value US$100,344
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
29.31
Quantity 18,248 -16.3%
Value US$534,885
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
29.31
Quantity 20,436 -15.4%
Value US$599,020
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
29.31
Quantity 5,000 -3.6%
Value US$146,560
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
29.31
Quantity 43,684
Value US$1,280,461
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
10.61
Quantity 4,073 -4.2%
Value US$43,215
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
20.02
Quantity 5,000 -4.9%
Value US$100,100
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
20.01
Quantity 5,000
Value US$100,050
US AxoGen, Inc. (AXGN)
Transaction date
Purchase
Price
6.22
Quantity 10,000 +14.2%
Value US$62,240
US AxoGen, Inc. (AXGN)
Transaction date
Purchase
Price
20.25
Quantity 5,000 +27.3%
Value US$101,250
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-11
US AxoGen, Inc. (AXGN)
PlS Planned sale
13,510 +2.9%
420.30
US$1,158,448 		13,510 +2.9% 420.30 US$1,158,448
2026-08-11 2026-08-11
US AxoGen, Inc. (AXGN)
PrS Proposed sale
80,916
151.26
US$2,212,561 		80,916 151.26 US$2,212,561
2026-05-12 2026-05-08
US AxoGen, Inc. (AXGN)
S Sale
1,290 -6.1%
220.81
US$3,283,688 		1,290 -6.1% 220.81 US$3,283,688
2026-05-08 2026-05-08
US AxoGen, Inc. (AXGN)
PrS Proposed sale
1,647
42.60
US$70,163 		1,647 42.60 US$70,163
2026-03-11 2026-03-10
B Purchase
1,475 +41.4%
68.03
US$100,344 		1,475 +41.4% 68.03 US$100,344
2025-12-17 2025-12-16
US AxoGen, Inc. (AXGN)
S Sale
18,248 -16.3%
29.31
US$534,885 		18,248 -16.3% 29.31 US$534,885
2025-12-17 2025-12-16
US AxoGen, Inc. (AXGN)
S Sale
20,436 -15.4%
29.31
US$599,020 		20,436 -15.4% 29.31 US$599,020
2025-12-17 2025-12-16
US AxoGen, Inc. (AXGN)
S Sale
5,000 -3.6%
29.31
US$146,560 		5,000 -3.6% 29.31 US$146,560
2025-12-16 2025-12-16
US AxoGen, Inc. (AXGN)
PrS Proposed sale
43,684
29.31
US$1,280,461 		43,684 29.31 US$1,280,461
2025-06-11 2025-06-09
US AxoGen, Inc. (AXGN)
S Sale
4,073 -4.2%
10.61
US$43,215 		4,073 -4.2% 10.61 US$43,215
2025-03-05 2025-03-03
US AxoGen, Inc. (AXGN)
PlS Planned sale
5,000 -4.9%
20.02
US$100,100 		5,000 -4.9% 20.02 US$100,100
2025-03-03 2025-03-03
US AxoGen, Inc. (AXGN)
PrS Proposed sale
5,000
20.01
US$100,050 		5,000 20.01 US$100,050
2023-09-08 2023-09-06
US AxoGen, Inc. (AXGN)
B Purchase
10,000 +14.2%
6.22
US$62,240 		10,000 +14.2% 6.22 US$62,240
2019-06-14 2019-06-13
US AxoGen, Inc. (AXGN)
B Purchase
5,000 +27.3%
20.25
US$101,250 		5,000 +27.3% 20.25 US$101,250